Table 1.
Demographics, clinical characteristics, and treatment of HAE patients
Parameters | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
Age, years | 33 | 48 | 30 | 27 |
Sex | Female | Female | Female | Female |
C1-INH plasma level, µg/mL | 37.16 | 34.83 | 11.26 | 59.00 |
C1-INH function, % | 116.39 | <7 | <7 | <7 |
C4 plasma level, µg/mL | 70.78 | 70.42 | 48.86 | 142.76 |
Genetic mutation | KNG1 | No pathogenic variant found | - | - |
Age at onset of HAE symptoms, years | 31 | 35 | 20 | - |
Family history of HAE | - | Daughter (patient 4) with HAE-C1-INH | Aunt (patient 2) had HAE-C1-INH | Mother (patient 2) with HAE-C1-INH |
Location of swelling | Face | Face, abdomen, extremities | Hands | Normal |
Treatment | Lanarimumab | Lanarimumab | - | - |
Patient improvement in frequency and/or severity of HAE attacks (Yes/No) | No | Yes | - | - |